Media
Press releases
Quotient Limited to Participate in Two Upcoming Conferences
JERSEY, Channel Islands, November 9, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today announced that the Company will participate in two upcoming virtual investor conferences.
Quotient Limited Reports Second Quarter Fiscal 2021 Results and Business Update
• FDA Emergency Use Authorization for the MosaiQ COVID-19 antibody test received
• FDA 510(k) clearance for Initial MosaiQ SDS microarray and MosaiQ instrument expected before the end of CY2020
• European field trial for Expanded MosaiQ IH microarray progressing; on track for CE Mark…
Quotient Limited to Report Second Quarter 2021 Financial Results and Host Conference Call
Quotient Limited Announces Receipt of U.S. FDA Emergency Use Authorization (EUA) for MosaiQ COVID-19 Antibody Test
JERSEY, Channel Islands, 28 September 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), headquartered in Eysins, Switzerland, today announced that on September 25, 2020, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Quotient's COVID-19…
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
JERSEY, Channel Islands, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT) (the "Company"), a commercial-stage diagnostics company, today announced the closing of its previously announced underwritten public offering of 20,294,117 ordinary shares at a price to the public…
Quotient Limited Announces Upsize and Pricing of Underwritten Offering of Ordinary Shares
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
Quotient Limited and Ortho Clinical Diagnostics Settle Arbitration and Sign Binding Letter of Intent Covering Patient Transfusion Diagnostics
Bloodworks Northwest Now Tests All Donors for COVID-19 Antibodies Looking for More Qualified Convalescent Plasma Donors
Testing Conducted Using the Highly Accurate MosaiQ COVID-19 Antibody Test from Quotient
Quotient Limited to Publish Quarterly Investor Presentation
JERSEY, Channel Islands, August 4, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020.